Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)

Neurology

Volumn 53, Issue 1, 1999, Pages 126-131

  Adams Jr , Harold P ^a   Davis, P H ^a   Leira, E C ^a   Chang, K C ^a   Bendixen, B H ^a   Clarke, W R ^a   Woolson, R F ^a   Hansen, M D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID;

ARTICLE; CLINICAL TRIAL; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STROKE; TREATMENT OUTCOME;

EID: 0344299275     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.1.126     Document Type: Article

References (24)

1. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28:2119-2125.
2. De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke 1993;24:1178-1181.
3. Fiorelli M, Alperovitch A, Argentino C, et al. Prediction of long-term outcome in the early hours following acute ischemic stroke. Italian Acute Stroke Study Group. Arch Neurol 1995; 52:250-255.
4. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996;27:1817-1820.
5. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Acute stroke. Prognosis and a prediction of the effect of medical treatment on outcome and health care utilization. The Copenhagen Stroke Study. Neurology 1997;49:1335-1342.
6. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction. A clinical examination scale. Stroke 1989;20:864-870.
7. Goldstein LR, Bertels C, Davis JN. Interrater reliability of the NIH Stroke Scale. Arch Neurol 1989;46:660-662.
8. Wityk RJ, Pessin MS, Kaplan RF, Caplan LR. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke 1994; 25:362-365.
9. Donnan GA, Dewey H, Davis SH, Thrift A. Acute brain infarction. Early changes in neurologic status. Cerebrovasc Dis 1997;7:6-9.
10. Goldstein LR, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997;28:307-310.
11. Caplan LR. New therapies for stroke. Arch Neurol 1997;54: 1222-1224.
12. Adams HP Jr, Bendixen BH, Rappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
13. The Publications Committee for the Trial of Org 10172 in Acute Stroke Treatment (TOAST) investigators. Low molecular weight heparinoid Org 10172 (danaparoid), and outcome after acute ischemic stroke. A randomized, controlled trial. JAMA 1998;279:1265-1272.
14. Albanese MA, Clarke WR, Adams HP Jr, Woolson RF, TOAST investigators. Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. Stroke 1994;25:1746-1751.
15. Gordon DL, Bendixen BH, Adams HP Jr, Rappelle LJ, Woolson RF, TOAST investigators. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke. Implications for clinical trials. Neurology 1993;43:1021-1027.
16. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
17. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind, placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS-II). Lancet 1998;352:1245-1251.
18. Madden KP, Karanjia PN, Adams HP Jr, Clarke WR, TOAST investigators. Accuracy of initial stroke subtype diagnosis in the TOAST study. Neurology 1995;45:1975-1979.
19. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
20. Warach S, Dashe JF, Edelmann RR. Clinical outcomes in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging. A preliminary analysis. J Cereb Blood Flow Metab 1996;16:53-59.
21. Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-580.
22. Koroshetz WJ, Gonzalez G. Diffusion-weighted MRI: an ECG for "brain attack"? Ann Neurol 1997;41:565-566.
23. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlates with clinical outcome. Ann Neurol 1997;42:164-170.
24. Powers WJ, Zivin J. Magnetic resonance imaging in acute stroke. Not ready for prime time. Neurology 1998;50:842-843.